Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area

Pharmacy Practice

  • Christine Damase-Michel1Department of Pharmacology, Research Unit of Pharmacoepidemiology, Faculty of Medicine, University of Toulouse III Paul Sabatier, FRANCE.
  • Juliette Pichereau1Department of Pharmacology, Research Unit of Pharmacoepidemiology, Faculty of Medicine, University of Toulouse III Paul Sabatier, FRANCE.
  • Atul Pathak1Department of Pharmacology, Research Unit of Pharmacoepidemiology, Faculty of Medicine, University of Toulouse III Paul Sabatier, FRANCE.
  • Isabelle Lacroix1Department of Pharmacology, Research Unit of Pharmacoepidemiology, Faculty of Medicine, University of Toulouse III Paul Sabatier, FRANCE.
  • Jean Louis Montastruc1Department of Pharmacology, Research Unit of Pharmacoepidemiology, Faculty of Medicine, University of Toulouse III Paul Sabatier, FRANCE.

Volume 6 Issue 1 Pages 15-19

Abstract

Aim/Background: Counselling or prescribing drugs during pregnancy requires health professionals to assess risk/benefit ratio for women and their baby. A misperception of the risk may lead to inappropriate decisions for pregnancy outcomes. The aim of the present study was to assess teratogenic and/or foetotoxic risk perception of common medications by general practitioners (GPs) and community pharmacists (CPs) from the Midi-Pyrenees area. Materials and Methods: 103 GPs and 104 CPs were interviewed. For 21 given drugs, a visual-analogue scale was used to evaluate the risk to give birth to a malformed infant if the mother had taken the drug during first trimester of pregnancy. For 9 drugs, health professionals had to say if they thought there was a potential foetotoxic and/or neonatal risk when drugs were administered during late pregnancy. Results: 97% and 91% of GPs and CPs respectively thought that isotretinoin and thalidomide are teratogenic and more than 80% thought that amoxicillin and acetaminophen are safe in early pregnancy. However, 19% of the GPs and 33% of CPs answered there were no teratogenic risk for valproate. Around 11% of both GPs and CPs said that warfarin was safe during pregnancy. For 22% of GPs and for 13% and 27% of CPs respectively, ibuprofen and enalapril were safe on late pregnancy. For each drug, mean value of perceived teratogenic risk by health professionals was higher than values that can be found in scientific references. Concerning isotretinoin, thalidomide and metoclopramide, perceived teratogenic risk was higher for CPs. Conclusion: These data show that the potential teratogenic and foetotoxic risk of several commonly used drugs is unknown by health professionals. Conversely, GPs and CPs who think that a risk exists, overestimate it. This misperception can lead to inappropriate decisions for pregnancy outcomes.

Keywords

  • Teratogens
  • Health Knowledge
  • Attitudes
  • Practice
  • France
Pharmacy Practice

Loading…